Article Versions Notes

Ravish A, Narasimhachar BC, Xi Z, Vishwanath D, Mohan A, Gaonkar SL, Chandrashekara PG, Ahn KS, Pandey V, Lobie PE, et al. Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells. Biomedicines. 2023; 11(10):2716. https://doi.org/10.3390/biomedicines11102716

Ravish, Akshay, Bhanuprakash C. Narasimhachar, Zhang Xi, Divakar Vishwanath, Arunkumar Mohan, Santosh L. Gaonkar, Paduvalahippe Gowdegowda Chandrashekara, Kwang Seok Ahn, Vijay Pandey, Peter E. Lobie, and et al. 2023. "Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells" Biomedicines 11, no. 10: 2716. https://doi.org/10.3390/biomedicines11102716

Ravish, A., Narasimhachar, B. C., Xi, Z., Vishwanath, D., Mohan, A., Gaonkar, S. L., Chandrashekara, P. G., Ahn, K. S., Pandey, V., Lobie, P. E., & Basappa, B. (2023). Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells. Biomedicines, 11(10), 2716. https://doi.org/10.3390/biomedicines11102716